Featured Research

from universities, journals, and other organizations

Radiation protection in pediatric radiology

Date:
July 5, 2011
Source:
Deutsches Aerzteblatt International
Summary:
The risk to children’s health from X-ray radiation is easy to reduce without compromising diagnostic accuracy, according to new research.

The risk to children's health from X-ray radiation is easy to reduce without compromising diagnostic accuracy. Gerhard Alzen and Gabriele Benz-Bohm describe some ways to achieve this in the current edition of Deutsches Δrzteblatt International.

The radiation risk is higher for children than for adults, as children's tissues have a higher cell division rate, and cells can be damaged during this process. Children's bodies also have a higher water content and therefore absorb more radiation, which can cause damage to their genes.

Pediatric doses of radiation should always comply with the ALARA (as low as reasonably achievable) principle. Radiation-induced damage can be reduced by the selection of an appropriate procedure, the technical specifications of the X-ray machine, use of the shortest possible scan times despite short target times, and the use of modern storage-plate systems. The child being examined can also help ensure that no additional images are needed by lying still, which, as the authors report, sometimes requires fixation devices.

However, one simple and important method of providing radiation protection is the correct use and positioning of layers of lead rubber to protect areas such as the gonads or eyes.


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Journal Reference:

  1. Alzen G, Benz-Bohm G. Radiation protection in pediatric radiology. Dtsch Arztebl Int, 2011; 108(24): 407%u201314 DOI: 10.3238/arztebl.2011.0407

Cite This Page:

Deutsches Aerzteblatt International. "Radiation protection in pediatric radiology." ScienceDaily. ScienceDaily, 5 July 2011. <www.sciencedaily.com/releases/2011/07/110704082704.htm>.
Deutsches Aerzteblatt International. (2011, July 5). Radiation protection in pediatric radiology. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/07/110704082704.htm
Deutsches Aerzteblatt International. "Radiation protection in pediatric radiology." ScienceDaily. www.sciencedaily.com/releases/2011/07/110704082704.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins